Summit Therapeutics grants chief accounting officer 100,000 restricted stock units
SMMT•Summit Therapeutics Chief Accounting Officer Bhaskar Anand received 100,000 common shares on October 8, 2026, bringing his directly held shares to 261,047.
1. Share award
Summit Therapeutics Chief Accounting Officer Bhaskar Anand received 100,000 common shares on October 8, 2026. The award brought his directly held shares to 261,047.
